Seroquel: biochemical profile of a potential atypical antipsychotic

Psychopharmacology

Volumn 112, Issue 2-3, 1993, Pages 285-292

  Saller, Charles F ^a   Salama, Andre I ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

5 HT2 receptor; Atypical antipsychotic; Clozapine; Dopamine metabolism; ICI 204,636; Seroquel

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; 3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FLUNITRAZEPAM; HALOPERIDOL; HOMOVANILLIC ACID; KETANSERIN; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; NORADRENALIN; PRAZOSIN; PROLACTIN; QUETIAPINE; QUINUCLIDINYL BENZILATE; RADIOLIGAND; RAUWOLSCINE; SEROTONIN; SEROTONIN 2 RECEPTOR; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OLFACTORY NUCLEUS; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; RECEPTOR OCCUPANCY;

ANIMAL; ANTIPSYCHOTIC AGENTS; BINDING, COMPETITIVE; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CLOZAPINE; COMPARATIVE STUDY; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; MALE; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, DOPAMINE D2; SEROTONIN ANTAGONISTS;

EID: 0027248858     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244923     Document Type: Article

References (41)

1. Typical and atypical antipsychotic occupancy of D-2 and S-2 receptors: an autoradiographic analysis in rat brain
2. Clozapine and haloperidol in the amygdaloid complex: differential effects on dopamine transmission with long-term treatment
3. Differential effect of subchronic treatment with various neuroleptic agents on serotonin-2 receptors in rat cerebral cortex
4. Clozapine-induced agranulocytosis
5. Tolerance phenomena with neuroleptics: catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol
6. Clozapine: neuroleptic-induced EPS and tardive dyskinesia
7. Pre-frontal cortex: possible site of antipsychotic action of haloperidol
8. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two sub-populations of mid-brain dopamine neurons
9. The risks and benefits of clozapine vs chlorpromazine
10. Clozapine and haloperidol in a single blind cross-over trial. Therapeutic and biochemical aspects in the treatment of schizophrenia
11. Seroquel: electrophysiological profile of a potential atypical antipsychotic
12. Binding characteristics of3H-prazosin to rat brain alpha-adrenergic receptors
13. Clozapine and agranulocytosis
14. [3H]8-Hydroxy-2-(di-n-propylamino), tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain
15. Characterization of [3H] rauwolsine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex
16. Clozapine in treatment-resistant schizophrenics
17. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain
18. [3H] Ketanserin (R 41 468), a selective [3H] ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role
19. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs
20. Repeated atypical neuroleptic administration: Effects on central dopamine metabolism monitored by in vivo voltammetry
21. Effects of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex
22. Clozapine — a potential antipsychotic agent without extrapyramidal manifestation
23. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values
24. Seroquel: behavioral profile of a potential atypical antipsychotic
25. Rapid automated analysis of biogenic amines and their metabolites using reverse-phase HPLC with electrochemical detection
26. Alterations in dopamine metabolism after chronic administration of haloperidol
27. 3-Methoxytyramine accumulation: effect of typical neuroleptics and various atypical compounds
28. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo
29. 5-Hydroxytryptamine-2 receptor down-regulation after chronic 5-hydroxytryptamine-2 antagonists
30. Dopamine receptor occupancy in vivo: measurement using N-ethoxy-2-ethoxy-1,2-dihydroquinoline (EEDQ)
31. 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade
32. The attractions of proteins for small molecules and ions
33. Brain dopamine receptors
34. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action of dopamine neurons
35. Clozapine, chlorpromaxine and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison
36. An anatomy of schizophrenia? Arch Gen D (1983) Neuroleptic-induced extrapyramidal reactions: classification, description and diagnosis
37. Neuroleptic-induced extrapyramidal reactions: classification, description and diagnosis
38. Sequence and significance of dopamine metabolism in the rat brain
39. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
40. Clozapine concentrations in brain regions: relationship to dopamine metabolite increase
41. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain